The tumor suppressor death-associated protein kinase targets to TCR-stimulated NF-kappa B activation |
| |
Authors: | Chuang Ya-Ting Fang Li-Wen Lin-Feng Ming-Hsien Chen Ruey-Hwa Lai Ming-Zong |
| |
Institution: | Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan. |
| |
Abstract: | Death-associated protein kinase (DAPK) is a unique multidomain kinase acting both as a tumor suppressor and an apoptosis inducer. The molecular mechanism underlying the effector function of DAPK is not fully understood, while the role of DAPK in T lymphocyte activation is mostly unknown. DAPK was activated after TCR stimulation. Through the expression of a dominant-negative and a constitutively active form of DAPK in T cells, we found that DAPK negatively regulated T cell activation. DAPK markedly affected T cell proliferation and IL-2 production. We identified TCR-induced NF-kappaB activation as a target of DAPK. In contrast, IL-1beta- and TNF-alpha-triggered NF-kappaB activation was not affected by DAPK. We further found that DAPK selectively modulated the TCR-induced translocation of protein kinase Ctheta, Bcl-10, and IkappaB kinase into membrane rafts. Notably, the effect of DAPK on the raft entry was specific for the NF-kappaB pathway, as other raft-associated molecules, such as linker for activation of T cells, were not affected. Our results clearly demonstrate that DAPK is a novel regulator targeted to TCR-activated NF-kappaB and T cell activation. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|